HHS’ drug pricing adviser dies: 4 things to know

HHS’ Senior Adviser for Drug Pricing Reform Dan Best has died, the department said Nov. 1.

Advertisement

Here are four things to know:

1. Of Mr. Best’s passing, CMS Administrator Seema Verma said: “I speak on behalf of all of us at CMS when I say that Dan Best was a remarkable member of our team. What a loss to our country and to all of us personally who had the great privilege of working with Dan.”

2. HHS did not specify the cause of Mr. Best’s death.

3. Before joining the Trump administration, where he helped lead efforts to lower drug prices, Mr. Best was vice president of industry relations for CVS Health, according to Bloomberg. He spent more than 10 years working for pharmacy benefit managers and attended a speech delivered by President Donald Trump Oct. 25 on actions to lower Medicare drug costs.

4. HHS Secretary Alex Azar commented on Mr. Best’s death in a statement to STAT: “It is with tremendous sadness that I learned of the passing of our friend and colleague. I had the great privilege to know Dan Best for the past decade. He joined me here at HHS out of a desire to serve the American people by making healthcare more affordable.”

More articles on leadership:
Democrats make final push on healthcare before midterms: 5 things to know
UNC Health Care CEO steps down to become interim university president
CEO of U of Mississippi Medical Center adult hospitals ousted after 2 years

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.